Results 161 to 170 of about 76,298 (277)

Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study. [PDF]

Biomolecules
Brouer IC, Zani A, Curman P, Ludwig RJ, Thaçi D.   +4 more
europepmc   +1 more source

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study

British Journal of Haematology, EarlyView.
Salomé Dahan, Stéphanie Guillet, Olivier Fain, Delphine Gobert, Stéphane Cheze, Florent Broca, Bertrand Godeau, Marc Michel   +7 more
wiley   +1 more source

Very Late-Onset Myasthenia Gravis in a Very Elderly Patient: Diagnostic Challenges and Importance of Early Recognition. [PDF]

Geriatrics (Basel)
Polimac Gorana N, Spiljak A.
europepmc   +1 more source

Liver Injury From Medications Used for Treating Inflammatory Bowel Disease: The Drug-Induced Liver Injury Network Experience. [PDF]

Liver Int
Gopalakrishna H, Gu J, Li YJ, Barnhart H, Halegoua-DeMarzio D, Bonkovsky HL, Barritt AS, Molleston JP, Chalasani NP, Ghabril M.   +9 more
europepmc   +1 more source

Case Report: Serum Protein Electrophoresis Incidentally Reveals Alpha-1 Antitrypsin Deficiency in p-ANCA-Positive Crescentic Glomerulonephritis. [PDF]

Int J Rheum Dis
Komac A, Serin N, Karadag DT, Baris SA, Cefle A.   +4 more
europepmc   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

European Journal of Haematology, EarlyView.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Myasthenia Gravis (MG) Resource Utilization, Epidemiology, Survival, and Treatment Patterns (MG-REST): Estimating the Clinical and Economic Burden in Ontario, Canada. [PDF]

Eur J Neurol
Barnett-Tapia C, Quansah K, Erman A, Nath N, Golden S, Ng R, Sharma A, Breiner A.   +7 more
europepmc   +1 more source

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

International Journal of Dermatology, EarlyView.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller, Helmut Beltraminelli, Wolf‐Henning Boehncke, Maximilian Böhm, Antonio Cozzio, Peter Häusermann, Ahmad Jalili, Antonios G. A. Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad   +11 more
wiley   +1 more source

Case Report: Pharmacological decision-making in pregnant women with neuromyelitis optica spectrum disorder: two contrasting clinical scenarios. [PDF]

Front Pharmacol
Wang CF, Zhang YF, Wei Q, Gong YH.
europepmc   +1 more source

Comparison of pharmacogenomic guidance in Australian prescribing resources and international pharmacogenomic guidelines

Internal Medicine Journal, EarlyView.
Abstract Background Pharmacogenomic‐guided medication management optimises drug therapy to enhance patient outcomes. Despite clinical utility, implementation in Australia remains limited, partly due to the lack of clear and consistent guidance. Aim This study evaluated the presence and consistency of pharmacogenomic testing indication categories and ...
Ruby Soueid, Jackson L. A. Thomas, Luke B. Hesson, Stephen Hughes, Sophie L. Stocker   +4 more
wiley   +1 more source